DOI: https://doi.org/10.26641/2307-0404.2019.3.181890

Clinical features of pregnancy in multidrug-resistant tuberculosis and type I diabetes mellitus comorbidities (a case report).

O. M. Raznatovska, A. V. Fedorec, M. O. Shalmina, T. A. Grekova

Abstract


Objective – to update the literature data with the clinical features of pregnancy in multidrug-resistant tuberculosis (MRD-TB) and type 1 diabetes mellitus (T1DM) comorbidities based on an example from own clinical experience. A clinical case of pregnancy course in MRD-TB and T1DM comorbidities was described based on our own clinical experience. We report the clinical case of newly diagnosed MRD-TB in a 38-year-old woman suffering from T1DM. Her general condition was unstable from satisfactory to moderately severe despite an adequate treatment of MRD-TB and T1DM with manifestations of intoxication syndrome and nephropathy. Adenomyosis with periodic bloody vaginal discharge was diagnosed. There was no clinical-radiological dynamics and sputum culture conversion. After an intensive phase of antimycobacterial therapy within 3 months, the patient got pregnant. Based on the medical indications (MRD-TB, absence of sputum culture conversion and clinical-radiological dynamics, moderate severity of T1DM, nephropathy) and adenomyosis with bloody vaginal discharge, the patient was requested to induce the pregnancy termination, and she consented. On month 7 of antimycobacterial therapy, an extensive drug-resistance of Mycobacterium tuberculosis to antimycobacterial agents and negative dynamics by follow-up chest X-ray were diagnosed. The feature of pregnancy course in MRD-TB and T1DM comorbidities was an unfavorable coexistence of both these diseases simultaneously resulting in an induced abortion. In this case, doctors to working with patients suffering from both MRD-TB and T1DM are recommended to advise patients the use of contraception in order to prevent pregnancy during treatment of active MRD-TB.


Keywords


pregnancy; multidrug-resistant tuberculosis; type 1 diabetes mellitus

Full Text:

PDF (English)

References


Jakovlev AA, Mordyk AV, Zhukova NV, Antro­pova VV, Leont'ev VV, Nikolaeva II. [Analysis of the course and outcome of tuberculosis and pregnancy when they are combined in patients of reproductive age]. Sibir­skoe medicinskoe obozrenie [Internet]. 2012;1(73). Russian. Available from: https://cyberleninka.ru/article/n/analiz-techeniya-i-ishodov-tuberkuleza-i-beremennosti-pri-ih-sochetanii-u-patsientok-reproduktivnogo-vozrasta.

Rahimdzhanova MT, Ismailov SI, Tashmano­va AB, Ahmedova MS. [The study of the course of preg­nancy and its outcomes with the analysis of possible risk factors in patients with type 1 diabetes]. Mezhdunarodnyi endokrinologicheskii zhurnal. 2014;2(58):28-30. Russian.

Nikonova LV, Tishkovskaja SV, Gadomskaja VI, Davydchik JV, Gulinskaja OV. [Diabetes and pregnancy. Part II. Course, patient management tactics]. J of the Grodno State Medical University. 2017;15(4):368-74. Russian. doi: https://doi.org/10.25298/2221-8785-2017-15-4-368-374.

Torosian KJ, Nepso JR, Novikova VA, Pen­zhojan GA. [Diabetes mellitus type 1 and pregnancy: a clinical perspective]. Sovremennye problemy nauki i obrazovanija [Internet]. 2016;4. Russian. Available from: http://www.science-education.ru/ru/article/view?id=24998.

[Unified clinical protocols of primary, secondary (specialized) and tertiary (highly specialized) medical care for adults "Tuberculosis": Ministry of Health of Ukraine Order No. 620 of December 31, 2014]. Kyiv, MOZ Ukrainy. 2014;171. Ukrainian.

Riza AL, Pearson F, Ugarte-Gil C, Alisjahbana B, van de Vijver S, Panduru NM, et al. Clinical management of concurrent diabetes and tuberculosis and the impli­cations for patient services. Lancet Diabetes Endocrinol. 2014;2(9):740-53.

Global report on diabetes. Geneva: World Health Organization. 2016;86.

Global Tuberculosis Report 2018. Geneva: World Health Organization. 2019;174.

Murphy HR, Elleri D, Allen JM, Harris J, Simmons D, Rayman G, et al. Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes. Diabetes Care. 2011;34:406-11. doi: https://doi.org/10.2337/dc10-1796

Rohilla M, Joshi B, Jain V, Kalra J, Prasad GRV. Multidrug-Resistant Tuberculosis during Pregnancy: Two Case Reports and Review of the Literature. Case Rep Obstet Gynecol. 2016:4. doi: https://doi.org/10.1155/2016/1536281

Gadallah MA, Mokhtar A, Rady M, El-Moghazy E, Fawzy M, Kandil SK. Prognostic factors of treatment among patients with multidrug-resistant tuberculosis in Egypt. J Formos Med Assoc. 2016;115(11):997-1003. doi: https://doi.org/10.1016/j.jfma.2015.10.002

Siddiqui A. Role of Diabetes in prevalence of Tuberculosis. J Diabetes Metab. 2011;2(9):170. doi: https://doi.org/10.4172/2155-6156.1000170


GOST Style Citations


  1. Анализ течения и исходов туберкулеза и беременности при их сочетании у пациенток репродуктивного возраста / А. А. Яковлев та ін. Сибирское медицинское обозрение. 2012. Т. 73, № 1. URL: https://cyberleninka.ru/article/n/analiz-techeniya-i-ishodov-tuberkuleza-i-beremennosti-pri-ih-sochetanii-u-patsientok-reproduktivnogo-vozrasta
  2. Рахимджанова М. Т., Исмаилов С. И., Ташма­нова А. Б., Ахмедова М. С. Изучение течения бере­менности и ее исходов с анализом возможных факто­ров риска у больных сахарным диабетом 1-го типа. Междунар. эндокринологический журнал. 2014. Т. 58, № 2. С. 28-30.
  3. Сахарный диабет и беременность. Часть ІІ. Течение, тактика ведения пациентов / Л. В. Никонова та ін. J. Grodno State Medical University. 2017. Vol. 15, No. 4. С. 368-374. DOI: https://doi.org/10.25298/2221-8785-2017-15-4-368-374
  4. Торосян К. Э., Непсо Ю. Р., Новикова В. А., Пенжоян Г. А. Сахарный диабет 1 типа и беремен­ность: клинические перспективы. Совр. проблемы науки и образования. 2016. № 4. URL: http://www.science-education.ru/ru/article/view?id=24998
  5. Уніфікований клінічний протокол первинної, вторинної (спеціалізованої) та третинної (висо­коспеціалізованої) медичної допомоги дорослим. Туберкульоз: наказ МОЗ України № 620 від 31.12.2014 р. Київ: МОЗ України, 2014. 171 с.
  6. Clinical management of concurrent diabetes and tuberculosis and the implications for patient services / A. L. Riza et al. Lancet Diabetes Endocrinology. 2014. Vol. 9, No. 2. С. 740-753. DOI: https://doi.org/10.1016/S2213-8587(14)70110-X
  7. Global report on diabetes. Geneva: World Health Organization, 2016. 86 р.
  8. Global Tuberculosis Report 2018. Geneva: World Health Organization, 2019. 174 р.
  9. Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes / H. R. Murphy et al. Diabetes Care. 2011. Vol. 34. Р. 406-411. DOI: https://doi.org/10.2337/dc10-1796
  10. Multidrug-Resistant Tuberculosis during Preg­nancy: Two Case Reports and Review of the Literature / M. Rohilla et al. Case Rep. Obstet. Gynecol. 2016. 4 р. DOI: https://doi.org/10.1155/2016/1536281
  11. Prognostic factors of treatment among patients with multidrug-resistant tuberculosis in Egypt / M. A. Gadallah et al. J. Formos Med Assoc. 2016. Vol. 115, No. 11. P. 997-1003. DOI: https://doi.org/10.1016/j.jfma.2015.10.002
  12. Siddiqui A. Role of Diabetes in prevalence of Tuberculosis. J. Diabetes Metab. 2011. Vol. 9, No. 2. Р. 170. DOI: https://doi.org/10.4172/2155-6156.1000170




 

This work is licensed under a Creative Commons Attribution 4.0 International License